Paracrine mediators of endometrial matrix metalloproteinase expression: Potential targets for progestin-based treatment of endometriosis

Annals of the New York Academy of Sciences

Volumn 955, Issue , 2002, Pages 139-146

  Osteen, Kevin G ^a   Bruner Tran, Kaylon L ^a   David, O N G ^a   Eisenberg, Esther ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endometriosis; MMPs; Retinoic acid; Transforming growth factor

Indexed keywords

CYTOKINE; GESTAGEN; GROWTH FACTOR; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PROGESTERONE; RETINOIC ACID; SEX HORMONE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL COMMUNICATION; CONFERENCE PAPER; CYTOKINE PRODUCTION; ENDOMETRIOSIS; ENDOMETRIUM; HUMAN; MENSTRUAL CYCLE; MENSTRUATION; MOUSE; NONHUMAN; PARACRINE SIGNALING; PERITONEAL CAVITY; PREGNANCY; PROTEIN EXPRESSION; RISK FACTOR; TISSUE DIFFERENTIATION; TISSUE GROWTH;

ANIMALIA;

EID: 0036215722     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb02774.x     Document Type: Conference Paper

References (36)

1. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity
2. Experimental endometriosis in the human
3. The relation of endometriosis to menstrual characteristics, smoking, and exercise
4. Endometriosis: Its association with retrograde menstruation, dysmenorrhea, and tubal pathology
5. Evidence for the risk of pelvic endometriosis by age, race, and socioeconomic status
6. Endometriosis and its medical management
7. Postmenopausal endometriosis
8. Medical treatment: Alternatives to danazol
9. Injectable depot medroxyprogesterone acetate contraception: An update for U.S. clinicians
10. Cyclic changes in the matrix metalloproteinase system in the ovary and uterus
11. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroids
12. Expression and localization of matrilysin (Pump-1, MMP-7), a matrix metalloproteinase in the human endometrium
13. Paracrine regulation of matrix metalloproteinase expression in the normal human endometrium
14. Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human tissue in nude mice
15. Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis
16. Establishment of experimental endometriosis by eutopic or ectopic endometrial tissue acquired from women with endometriosis cannot be prevented by progesterone treatments
17. Endometriosis and nuclear hormone receptors
18. Interleukin-1α opposes suppression of human endometrial matrix metalloproteinases by progesterone in a model of experimental endometriosis
19. Progesterone exposure prevents matrix metalloproteinase-3 (MMP-3) stimulation by interleukin-1α in human endometrial stromal cells
20. Progesterone or retinoic acid treatment of human endometrial tissue reduces basal and cytokine-stimulated MMP expression and increases TIMP-1 secretion
21. Retinoic acid synthesis and expression of cellular retinol-binding protein and cellular retinoic acid-binding protein type II are concurrent with decidualization of rat uterine stromal cells
22. Tissue changes following deprivation of fat soluble vitamin A
23. Retinoic acid receptors and cellular retinoid binding proteins: Complex interplay in retinoid signaling
24. Cellular retinoid binding proteins and nuclear retinoic acid receptors in endometrial epithelial cells
25. Variation in the expression of cellular retinoid binding proteins in human endometrium throughout the menstrual cycle
26. The AP-1 site and MMP gene regulation: What is all the fuss about?
27. Early endometriosis invades the extracellular matrix
28. Steroid and growth factor regulation of matrix metalloproteinase expression and endometriosis
29. Progesterone and transforming growth factor-β co-mediate matrix metalloproteinase expression in a model of endometriosis
30. Transforming growth factor-β mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma
31. The role for transforming growth factor-β (TGF-β) in human cancer
32. Blood plasma levels of lipoperoxides, glutathione peroxidase, beta carotene, vitamin A and E in women with habitual abortion
33. A subset of patients with recurrent spontaneous abortion is deficient in transforming growth factor beta-2-producing "suppressor cells" in uterine tissue near the placental attachment site
34. Cytokine regulation of metalloproteinase gene expression
35. The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes: Transcriptional and posttranscriptional regulation, signal transduction, and cell-type-specific expression